marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
TG Therapeutics Cash Flow 2011-2024 | TGTX
Annual Cash Flow TG Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-31.4 M | -176 M | -296 M | -215 M | -133 M | -129 M | -93.8 M | - | - | - | - | -5.19 M | -86.6 K |
Depreciation & Amortization |
211 K | 303 K | 282 K | 158 K | 100 K | 88 K | 82 K | 63 K | 15.5 K | 3.93 K | 1.13 K | 235 | - |
Accounts Payables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
51.1 M | - | 1.39 M | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
39.8 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow TG Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -8.21 M | - | - | - | -59.9 M | - | -152 M | -118 M | -68.7 M | - | -209 M | -142 M | -81.4 M | - | -162 M | -106 M | -62.1 M | - | -102 M | -69.2 M | -33.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.2 M | - | -4.35 M | -1.36 M | -862 K | - | -30.1 K | - | - |
Depreciation & Amortization |
- | - | 29 K | - | - | - | 68 K | - | 230 K | 154 K | 76 K | - | 202 K | 126 K | 59 K | - | 105 K | 64 K | 30 K | - | 72 K | 46 K | 23 K | - | 64 K | 41 K | 20 K | - | 62 K | 41 K | 20 K | - | 42.5 K | 23.3 K | 6.38 K | - | 10.3 K | 5.8 K | 2.42 K | - | 2.45 K | 1.56 K | 706 | - | 634 | 309 | 115 | - | 118 | - | - | - | - | - | - |
Accounts Payables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
116 M | 83.6 M | 65 M | 51.1 M | 39.3 M | 17.5 M | 8.62 M | - | - | 88 K | 903 K | 1.39 M | 1.38 M | 931 K | 771 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 152 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
84.7 M | 81.2 M | 77.7 M | 39.8 M | 33.6 M | 30.2 M | 27.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency